There are two key points here. The minister already touched on this earlier.
Moderna and Pfizer are certainly the workhorses or make up the biggest volume in terms of meeting those targets. Clearly, to the extent that AstraZeneca is rolled out, that only helps matters, but I would say, in terms of meeting the targets that are out there, it's largely a story on Moderna and Pfizer.